Skip to main content
SpringerLink
Log in

No effect of recombinant human interleukin-1 on numbers of peripheral blood and peritoneal leukocytes during acute inflammation

  • Original Articles
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Recombinant human interleukin-1 (IL-1) can prolong the survival of mice with severe systemic bacterial or fungal infections. In order to assess whether this is due to an effect of IL-1 on the production of leukocytes or their migration to the site of infection, the influence of IL-1 on the influx of leukocytes to the site of an acute inflammation was studied in normal and in granulocytopenic mice. The numbers of granulocytes, lymphocytes, and monocytes or macrophages in both the circulation and the peritoneal cavity were determined during an acute sterile inflammation elicited by intraperitoneal injection of either newborn calf serum (NBCS) or heat-killedCandida albicans, and during a peritoneal infection with viableC. albicans. After normal mice were injected intraperitoneally with NBCS or 107 CFU heat-killed or viableC. albicans, the number of peritoneal granulocytes rose sharply within 6 h. Pretreatment of mice with a single intraperitoneal dose of 80 ng IL-1 24 h before injection of an inflammatory stimulus did not influence the course of the numbers of leukocytes in the circulation or in the peritoneal cavity. When mice were rendered granulocytopenic by cyclophosphamide, both the influx of granulocytes into the peritoneal cavity and the concomitant rise in the number of peripheral blood granulocytes after injection of NBCS, killed or viableC. albicans was virtually absent. Pretreatment of granulocytopenic mice with IL-1 did not influence the course of the numbers of leukocytes in either the circulation or the peritoneal cavity. These findings show that the beneficial effect of a single dose of IL-1 on the course of candidal infections in normal or granulocytopenic mice is not attributable to the influx of granulocytes or monocytes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Oppenheim, J. J., A. Togawa, L. Chedid, andS. Mizel. 1980. Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor.Cell. Immunol. 50:71–81.

    Google Scholar 

  2. Oppenheim, J. J., E. J. Kovacs, K. Matsushima, andS. K. Durum. 1986. There is more than one interleukin-1.Immunol. Today 7:45–56.

    Google Scholar 

  3. Dinarello, C. A. 1984. Interleukin-1.Rev. Infect. Dis. 6:51–95.

    Google Scholar 

  4. Ozaki, Y., A. Ohashi, A. Minami, andS. Nakamura. 1987. Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1α.Infect. Immun. 55:1436–1440.

    Google Scholar 

  5. Van der Meer, J. W. M., M. Barza, S. M. Wolff, andC. A. Dinarello. 1988. A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection.Proc. Natl. Acad. Sci. U.S.A. 85:1620–1623.

    Google Scholar 

  6. Van der Meer, J. W. M. 1988. The effects of recombinant interleukin-1 and recombinant tumor necrosis factor on non-specific resistance to infection.Biotherapy 1:19–25.

    Google Scholar 

  7. Czuprynski, C. J., andJ. F. Brown. 1987. Recombinant murine interleukin-1α enhancement of nonspecific antibacterial resistance.Infect. Immun. 55:2061–2065.

    Google Scholar 

  8. Vant Wout, J. W., J. W. M. Van der Meer, M. Barza, andC. A. Dinarello. 1988. Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin 1.Eur. J. Immunol. 18:1143–1146.

    Google Scholar 

  9. Czuprynski, C. J., andJ. F. Brown. 1987. Purified human and recombinant murine interleukin-1 induced accumulation of inflammatory peritoneal neutrophils and mononuclear phagocytes: Possible contributions to antibacterial resistance.Microb. Pathogen. 3:377–386.

    Google Scholar 

  10. Czuprynski, C. J., J. F. Brown, K. M. Young, A. J. Cooley, andR. S. Kurtz. 1988. Effects of murine recombinant interleukin 1 alpha on the host response to bacterial infection.J. Immunol. 140:962–968.

    Google Scholar 

  11. McIntyre, K. W., J. Unowsky, W. Delorenzo, andW. Benjamin. 1989. Enhancement of antibacterial resistance of neutropenic bone marrow-suppressed mice by interleukin-1α.Infect. Immun. 57:48–54.

    Google Scholar 

  12. Stork, L. C., V. M. Peterson, C. H. Rundus, andW. A. Robinson. 1988. Interleukin-1 enhances murine granuiopoiesis in vivo.Exp. Hematol. 16:163–167.

    Google Scholar 

  13. Fibbe, W. E., M. R. Daha, P. S. Hiemstra, N. Duinkerken, E. Lurvink, P. Ralph, B. W. Altrock, K. Kaushansky, R. Willemze, andJ. H. Falkenburg. 1989. Interleukin 1 and poly(rI).poly(rC) induce production of granulocyte CSF, macrophage CSF, and granulocytemacrophage CSF by human endothelial cells.Exp. Hematol. 17:229–234.

    Google Scholar 

  14. Fibbe, W. E., J. Van Damme, A. Billiau, H. M. Goselink, P. J. Voogt, G. Van Eeden, P. Ralph, B. Altrock, andJ. H. F. Falkenburg. 1988. Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor.Blood 71:430–435.

    Google Scholar 

  15. Fibbe, W. E., J. Van Damme, A. Billiau, P. J. Voogt, N. Duinkerken, P. M. C. Kluck, andJ. H. F. Falkenburg. 1986. Interleukin-1 (22-k factor) induces release of granulocytemacrophage colony-stimulating activity from human mononuclear phagocytes.Blood 68:1316–1321.

    Google Scholar 

  16. Vogel, S. N., S. D. Douches, E. N. Kaufman, andR. Neta. 1987. Induction of colony stimulating factor in vivo by recombinant interleukin 1 alpha and recombinant tumor necrosis factor alpha.J. Immunol. 138:2143–2148.

    Google Scholar 

  17. Zucali, J. R., C. A. Dinarello, D. J. Oblon, M. A. Gross, L. Anderson, andR. S. Weiner. 1986. Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colonystimulating activity and prostaglandin E2.J. Clin. Invest. 77:1857–1863.

    Google Scholar 

  18. Kullberg, B. J., J. W. Van't Wout, andR. Van Furth. 1990. Role of granulocytes in enhanced host resistance to Candida albicans induced by recombinant interleukin-1.Infect. Immun. 58:3319–3324.

    Google Scholar 

  19. Vant Wout, J. W., I. Linde, P. C. J. Leijh, andR. Van Furth. 1989. Effect of irradiation, cyclophosphamide, and etoposide (VP-16) on number of peripheral blood and peritoneal leukocytes in mice under normal conditions and during acute inflammatory reaction.Inflammation 13:1–14.

    Google Scholar 

  20. Van Furth, R., andZ. A. Cohn. 1968. The origin and kinetics of mononuclear phagocytes.J. Exp. Med. 128:415–433.

    Google Scholar 

  21. Kaplow, L. S. 1965. Simplified myeloperoxidase stain using benzidine dihydrochloride.Blood 26:215–219.

    Google Scholar 

  22. Sluiter, W., E. Hulsing-Hesselink, I. Elzenga-Claasen, andR. Van Furth. 1985. Method to select mice in the steady state for biological studies.J. Immunol. Methods 760:135–143.

    Google Scholar 

  23. Vant Wout, J. W., I. Linde, P. C. J. Leijh, andR. Van Furth. 1988. Contribution of granulocytes and monocytes to resistance against experimental disseminatedCandida albicans infections.Eur. J. Clin. Microbiol. Infect. Dis. 7:736–741.

    Google Scholar 

  24. Benjamin, W. R., N. S. Tare, T. J. Hayes, J. M. Becker, andT. D. Anderson. 1989. Regulation of hemopoiesis in myelosuppressed mice by human recombinant IL-1 alpha.J. Immunol. 142:792–799.

    Google Scholar 

  25. Fibbe, W. E., J. W. M. Van der Meer, J. H. F. Falkenburg, M. S. Hamilton, P. M. Kluin, andC. A. Dinarello. 1989. A single low dose of human recombinant interleukin 1 accelerates the recovery of neutrophils in mice with cyclophosphamide-induced neutropenia.Exp. Hematol. 17:805–808.

    Google Scholar 

  26. Moreb, J. 1989. Protective effects of IL-1 on human hematopoietic progenitor cells treated in vitro with 4-hydroperoxycyclophosphamide.J. Immunol. 142:1937–1942.

    Google Scholar 

  27. Stork, L., L. Barczuk, M. Kissinger, andW. Robinson. 1989. Interleukin-1 accelerates murine granulocyte recovery following treatment with cyclophosphamide.Blood 73:938–944.

    Google Scholar 

  28. Minami, A., K. Fujimoto, Y. Ozaki, andS. Nakamura. 1988. Augmentation of host resistance to microbial infections by recombinant human interleukin-1α.Infect. Immun. 56:3116–3120.

    Google Scholar 

  29. Annema, A., W.Sluiter, and R.Van Furth. 1991. Effect of interleukin-1, macrophage colony-stimulating factor, and factor increasing monocytopoiesis on the production of leukocytes in mice.Exp. Hematol. (accepted).

  30. Sayers, T. J., T. A. Wiltrout, C. A. Bull, A. C. Denn, III, A. M. Pilaro, andB. Lokesh. 1988. Effect of cytokines on polymorphonuclear neutrophil infiltration in the mouse. Prostaglandinand leukotriene-independent induction of infiltration by IL-1 and tumor necrosis factor.J. Immunol. 141:1670–1677.

    Google Scholar 

  31. Sauder, D. N., N. L. Mouneessa, S. I. Katz, C. A. Dinarello, andJ. I. Gallin. 1984. Chemotactic cytokines: the role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis.J. Immunol. 132:828–832.

    Google Scholar 

  32. Yoshimura, T., K. Matsushima, J. J. Oppenheim, andE. J. Leonard. 1987. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: Partial characterization and separation from interleukin-1 (IL1).J. Immunol. 139:788–793.

    Google Scholar 

  33. Gladue, R., A. Girard, andM. Newborg. 1988. Enhanced antibacterial resistance in neutropenic mice treated with human recombinant interleukin-1 beta.Agents Actions 24:130–136.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Infectious Diseases, University Hospital, P.O. Box 9600, 2300 RC, Leiden, The Netherlands

    Bart-Jan Kullberg, Jan W. Van't Wout & Ralph Van Furth

Authors
  1. Bart-Jan Kullberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jan W. Van't Wout
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ralph Van Furth
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kullberg, BJ., Wout, J.W.V. & Van Furth, R. No effect of recombinant human interleukin-1 on numbers of peripheral blood and peritoneal leukocytes during acute inflammation. Inflammation 15, 457–470 (1991). https://doi.org/10.1007/BF00923343

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00923343

Keywords

Search

Navigation